Unknown

Dataset Information

0

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.

ABSTRACT: Sepsis, a potentially life-threatening complication of an infection, has the highest burden of death and medical expenses in hospitals worldwide. Leukocyte count and CD64 expression on neutrophils (nCD64) are known to correlate strongly with improved sensitivity and specificity of sepsis diagnosis at its onset. A major challenge is the lack of a rapid and accurate point-of-care (PoC) device that can perform these measurements from a minute blood sample. Here, we report a PoC microfluidic biochip to enumerate leukocytes and quantify nCD64 levels from 10??l of whole blood without any manual processing. Biochip measurements have shown excellent correlation with the results from flow cytometer. In clinical studies, we have used PoC biochip to monitor leukocyte counts and nCD64 levels from patients' blood at different times of their stay in the hospital. Furthermore, we have shown the biochip's utility for improved sepsis diagnosis by combining these measurements with electronic medical record (EMR).

SUBMITTER: Hassan U 

PROVIDER: S-EPMC5500847 | biostudies-other | 2017 Jul

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.

Hassan U U   Ghonge T T   Reddy B B   Patel M M   Rappleye M M   Taneja I I   Tanna A A   Healey R R   Manusry N N   Price Z Z   Jensen T T   Berger J J   Hasnain A A   Flaugher E E   Liu S S   Davis B B   Kumar J J   White K K   Bashir R R  

Nature communications 20170703

Sepsis, a potentially life-threatening complication of an infection, has the highest burden of death and medical expenses in hospitals worldwide. Leukocyte count and CD64 expression on neutrophils (nCD64) are known to correlate strongly with improved sensitivity and specificity of sepsis diagnosis at its onset. A major challenge is the lack of a rapid and accurate point-of-care (PoC) device that can perform these measurements from a minute blood sample. Here, we report a PoC microfluidic biochip  ...[more]

Similar Datasets

Unknown A microfluidic biochip for complete blood cell counts at the point-of-care.
| S-EPMC4761450 | biostudies-literature
Unknown Identification of suitable controls for miRNA quantification in T-cells and whole blood cells in sepsis.
| S-EPMC6823537 | biostudies-literature
Unknown Design and Utility of a Point-of-Care Microfluidic Platform to Assess Hematocrit and Blood Coagulation.
| S-EPMC6519743 | biostudies-literature
Unknown Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip.
| S-EPMC6469871 | biostudies-literature
Unknown Biomarkers for Point-of-Care Diagnosis of Sepsis.
| S-EPMC7143187 | biostudies-literature
Unknown Neutrophil CD64 as a diagnostic marker in neonatal sepsis.
| S-EPMC3375383 | biostudies-literature
Unknown Study To Evaluate the Performance of a Point-of-Care Whole-Blood HIV Viral Load Test (SAMBA II HIV-1 Semi-Q Whole Blood).
| S-EPMC8106730 | biostudies-literature
Unknown Thermally-actuated microfluidic membrane valve for point-of-care applications.
| S-EPMC8433387 | biostudies-literature
Unknown A simple check valve for microfluidic point of care diagnostics.
| S-EPMC5089928 | biostudies-literature
Unknown Impact of High-Dose Intravenous Vitamin C for Treatment of Sepsis on Point-of-Care Blood Glucose Readings.
| S-EPMC8256056 | biostudies-literature